SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-09-033300
Filing Date
2009-06-18
Accepted
2009-06-18 16:29:52
Documents
3
Period of Report
2009-07-30
Effectiveness Date
2009-06-18

Document Format Files

Seq Description Document Type Size
1 v152563_def14a.htm DEF 14A 1437055
2 GRAPHIC logopg1.jpg GRAPHIC 567
3 GRAPHIC logopg2.jpg GRAPHIC 6466
  Complete submission text file 0001144204-09-033300.txt   1448498
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 09899056
SIC: 2834 Pharmaceutical Preparations